Vertex Pharmaceuticals Inc/  US92532F1003  /

Cboe Europe BXE
2024-08-26  9:13:13 AM Chg. - Volume Bid5:28:32 PM Ask5:28:32 PM Market Capitalization Dividend Y. P/E Ratio
429.55EUR - 3
Turnover: 1,288.65
-Bid Size: - -Ask Size: - 113.17 bill.EUR - -

Assets

2012
US GAAP
in mill. USD
2013
US GAAP
in mill. USD
2014
US GAAP
in mill. USD
2015
US GAAP
in mill. USD
2016
US GAAP
in mill. USD
Property and Equipment
  433.6000   696.9000   715.8120   697.7150   698.3620
Intangible Assets
  663.5000   0.0000   29   284.3400   284.3400
Long-Term Investments
  31.9000   .1000   -   -   20.2760
Fixed Assets
  -   -   788.1680   1,091.7220   -
Inventories
  30.5000   14.1000   30.8480   57.2070   77.6040
Accounts Receivable
  143.3000   85.5000   75.9640   177.6390   201.0830
Cash and Cash Equivalents
  489.4000   569.3000   625.2590   714.7680   1,183.9450
Current Assets
  1,589.6000   1,588.6000   1,546.5110   1,407.1530   1,831.5400
Total Assets
  2,759.3000   2,319   2,334.6790   2,498.8750   2,896.7870

 

Liabilities

2012
US GAAP
in mill. USD
2013
US GAAP
in mill. USD
2014
US GAAP
in mill. USD
2015
US GAAP
in mill. USD
2016
US GAAP
in mill. USD
Accounts Payable
  101.3000   49.3000   71.1940   74.9420   61.4510
Long-term debt
  -   -   792.9350   739.3970   521.3350
Liabilities to Banks
  0.0000   0.0000   280.6000   224   0.0000
Provisions
  281.1000   -   -   110.4000   134.1000
Liabilities
  1,563.4000   962.6000   1,238.4960   1,405.2470   1,558.5960
Share Capital
  -   -   2.3850   2.4270   2.4500
Total Equity
  1,195.9000   1,356.4000   1,096.1830   1,093.6280   1,338.1910
Minority Interests
  196.7000   0.0000   21.1770   153.6610   181.6090
Total liabilities equity
  2,759.3000   2,319   2,334.6790   2,498.8750   2,896.7870

 

Income Statement

2012
US GAAP
in mill. USD
2013
US GAAP
in mill. USD
2014
US GAAP
in mill. USD
2015
US GAAP
in mill. USD
2016
US GAAP
in mill. USD
Revenues
  1,527   1,212   580.4150   1,032.3360   1,702.1770
Depreciation (total)
  -   -   63.2570   62.3430   61.3980
Operating Result
  2.3000   -903.4000   -692.4120   -466.8790   9.9360
Interest Income
  -14.8000   -22.7000   72.8630   84.2060   81.4320
Income Before Taxes
  -12.4000   -976.1000   -734.8750   -557.8000   -67.3660
Income Taxes
  38.8000   -288.6000   6.9580   30.3810   16.6650
Minority Interests Profit
  -55.9000   242.5000   4.1900   31.8470   -28.0210
Net Income
  -107   -445   -738.5550   -556.3340   -112.0520

 

Per Share

2012
US GAAP
in USD
2013
US GAAP
in USD
2014
US GAAP
in USD
2015
US GAAP
in USD
2016
US GAAP
in USD
Earnings per Share
  -0.5000   -1.9800   -3.1400   -2.3100   -0.4600
Dividend per Share
  0.0000   0.0000   -   -   -

 

Cash Flow

2012
US GAAP
in mill. USD
2013
US GAAP
in mill. USD
2014
US GAAP
in mill. USD
2015
US GAAP
in mill. USD
2016
US GAAP
in mill. USD
Cash Flow from Operating Activities
  267.8000   -51.6000   -513.1990   -365.4320   236.1030
Cash Flow from Investing Activities
  -425.8000   -54.1000   73.9590   268.8560   104.4690
Cash Flow from Financing
  172.2000   180.9000   497.3760   188.9190   133.2710
Decrease / Increase in Cash
  14.1000   79.9000   55.9600   89.5090   469.1770
Employees
  2,200   1,800   1,830   1,950   2,150